Using MRI to Study Bone Marrow in Hodgkin's Disease
Author Information
Author(s): S.R. Smith, C.E. Williams, R.H.T. Edwards, J.M. Davies
Primary Institution: University of Liverpool
Hypothesis
Can quantitative magnetic resonance imaging (MRI) effectively assess bone marrow involvement in patients with Hodgkin's disease undergoing autologous bone marrow transplantation?
Conclusion
Quantitative MRI can detect abnormal areas in bone marrow and assess treatment responses in patients with Hodgkin's disease.
Supporting Evidence
- Four patients showed elevated TI values suggestive of bone marrow involvement with Hodgkin's disease.
- Serial studies indicated normalization of TI values post-transplant.
- Significant correlation between T2 relaxation rate and CFU-GM of processed bone marrow was observed.
Takeaway
Doctors used special MRI scans to see if patients with Hodgkin's disease had cancer in their bone marrow before treatment, and it helped them understand how well the treatment worked afterward.
Methodology
Fifteen patients underwent quantitative MRI studies of the lumbar spine before and after autologous bone marrow transplantation.
Potential Biases
Potential sampling errors in bone marrow biopsy may lead to false negatives.
Limitations
The study did not include biopsies of the lumbar vertebral marrow, which may limit the confirmation of MRI findings.
Participant Demographics
Fifteen patients (8 female, 7 male, ages 19-46) with refractory or relapsed Hodgkin's disease.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website